4P-Pharma Welcomes New Board Members: Marina Vasiliou, Christian Bechon, and Alain Sainsot

Monday, 9 September 2024, 22:29

4P-Pharma welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot as new independent members of its Board. Their extensive expertise strengthens the company’s leadership. Revital Rattenbach, CEO of 4P-Pharma, states the importance of these appointments. With a commitment to innovation, 4P-Pharma continues to progress in the biotech field.
LivaRava_Medicine_Default.png
4P-Pharma Welcomes New Board Members: Marina Vasiliou, Christian Bechon, and Alain Sainsot

The Significance of New Board Members

4P-Pharma proudly welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot as independent members. Each member brings extensive experience from various sectors in healthcare and biopharmaceuticals. Revital Rattenbach, the CEO, emphasizes their proven leadership abilities.

Boosting Corporate Governance

  • Marina Vasiliou has a rich background in medical research.
  • Christian Bechon excels in business strategy.
  • Alain Sainsot is known for innovation in health technologies.

These appointments align with 4P-Pharma’s mission to innovate and expand its impact in the industry.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe